Oral Oncology
Volume 40, Issue 7 , Pages 728-735 , August 2004

Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells

  • Michelle Agostini

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP 52, Areão, Piracicaba, SP 13414-018, Brazil
    • ,
  • Sabrina D. Silva

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP 52, Areão, Piracicaba, SP 13414-018, Brazil
    • ,
  • Karina G. Zecchin

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP 52, Areão, Piracicaba, SP 13414-018, Brazil
    • ,
  • Ricardo D. Coletta

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP 52, Areão, Piracicaba, SP 13414-018, Brazil
    • ,
  • Jacks Jorge

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP 52, Areão, Piracicaba, SP 13414-018, Brazil
    • ,
  • Massimo Loda

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
    • ,
  • Edgard Graner

      Affiliations

    • Department of Oral Diagnosis, School of Dentistry of Piracicaba, UNICAMP, Av. Limeira 901, CP 52, Areão, Piracicaba, SP 13414-018, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55-19-3412-5318; fax: +55-19-3412-5218

Received 10 December 2003 ,Accepted 7 January 2004.

References 

  1. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000;16(3):202–208
  2. Baron A, Migita T, Tang D, Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer?. J. Cell Biochem. 2004;91(1):47–53
  3. Brink J, Ludtke SJ, Yang C, Gu Z, Wakil SJ, Chiu W. Quaternary structure of human fatty acid synthase by electron cryomicroscopy. Proc. Natl. Acad. Sci. USA. 2002;99(1):138–143
  4. Weiss L, Hoffmann GE, Schreiber R, Andres H, Fuchs E, Korber E, et al.  Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol. Chem Hoppe Seyler. 1986;367(9):905–912
  5. Chirala SS, Chang H, Matzuk M, Abu-Elheiga L, Mao J, Mahon K, et al.  Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero. Proc. Natl. Acad. Sci. USA. 2003;100(11):6358–6363
  6. Pizer ES, Wood FD, Heine HS, Romantsev FE, Pasternack GR, Kuhajda FP. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res. 1996;56(6):1189–1193
  7. Krontiras H, Roye GD, Beenken SE, Myers RB, Mayo MS, Peters GE, et al.  Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue. Head Neck. 1999;21(4):325–329
  8. Oskouian B. Overexpression of fatty acid synthase in SKBR3 breast cancer cell line is mediated via a transcriptional mechanism. Cancer Lett. 2000;149(1–2):43–51
  9. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC, et al.  The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum. Pathol. 2000;31(9):1068–1073
  10. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, et al.  Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412(6849):822–826
  11. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (AO-519) as a predictor of progression of protaste cancer. Hum. Pathol. 1996;27(9):917–921
  12. Kusakabe T, Nashimoto A, Honma K, Suzuki T. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology. 2002;40(1):71–79
  13. Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, Baert L, et al.  Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int. J. Cancer. 2002;98(1):19–22
  14. Innocenzi D, Alo PL, Balzani A, Sebastiani V, Silipo V, La Torre G, et al.  Fatty acid synthase expression in melanoma. J. Cutan. Pathol. 2003;30(1):23–28
  15. Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, et al.  Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol. Cancer Res. 2003;1(10):707–715
  16. Visca P, Sebastiani V, Pizer ES, Botti C, De Carli P, Filippi S, et al.  Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma. Anticancer Res. 2003;23(1A):335–339
  17. Takahiro T, Shinichi K, Toshimitsu S. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Clin. Cancer Res. 2003;9(6):2204–2212
  18. Alo PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer. 1996;77(3):474–482
  19. Gansler TS, Hardman W, Hunt DA, Schaffel S, Hennigar RA. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum. Pathol. 1997;28(6):686–692
  20. Visca P, Alo PL, Del Nonno F, Botti C, Trombetta G, Marandino F, et al.  Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent non neoplastic mucosa. Clin. Cancer Res. 1999;5(12):4111–4118
  21. Alo PL, Visca P, Framarino ML, Botti C, Monaco S, Sebastiani V, et al.  Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol. Rep. 2000;7(6):1383–1388
  22. Lacasa D, Le Liepvre X, Ferre P, Dugail I. Progesterone stimulates adipocyte determination and differentiation 1/sterol regulatory element-binding protein 1c gene expression: potential mechanism for the lipogenic effect of progesterone in adipose tissue. J. Biol. Chem. 2001;276(15):11512–11516
  23. Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W, Verhoeven G. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene. 2000;19(45):5173–5181
  24. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res. 1997;57(6):1086–1090
  25. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV. Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol. Endocrinol. 2001;15(10):1817–1828
  26. Van de Sande T, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV. Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP protaste cancer cells. Cancer Res. 2002;62(3):642–646
  27. Pizer ES, Pflug BR, Bova GS, Han WF, Udan MS, Nelson JB. Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression. Prostate. 2001;47(2):102–110
  28. Myers RB, Oelschlager DK, Weiss HL, Frost AR, Grizzle WE. Fatty acid synthase: an early molecular marker of progression of prostatic adenocarcinoma to androgen independence. J. Urol. 2001;165(3):1027–1032
  29. Furuya Y, Akimoto S, Yasuda K, Ito H. Apoptosis in androgen-independent prostate cell line induced by inhibition of fatty acid synthesis. Anticancer Res. 1997;17(6D):4589–4593
  30. Pizer ES, Chrest FJ, DiGiuseppe JA, Han WF. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res. 1998;58(20):4611–4615
  31. Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, et al.  Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res. 2001;61(4):1493–1499
  32. Swinnen JV, Van Veldhoven PP, Timmermans L, De Schrijver E, Brusselmans K, Vanderhoydonc F, et al.  Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. Biochem. Biophys. Res. Commun. 2003;302(4):898–903
  33. Ettenberg SA, Magnifico A, Cuello M, Nau MM, Rubstein XR, Yarden Y, et al.  cbl-b-Dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J. Biol. Chem. 2001;276(29):27677–27684
  34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72(7):248–254
  35. Sanguinetti CJ, Dias Neto E, Simpson AJ. Rapide silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques. 1994;17(5):914–921
  36. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res. 2003;63(1):132–139
  37. Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN, et al.  Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res. 1995;55(14):3140–3148
  38. Konger RL, Chan TC. Epidermal growth factor terminal differentiation in human epidermoid carcinoma cells. J. Cell. Physiol. 1993;156(3):515–521
  39. O-Charoenrat P, Rhys-Evans P, Court WJ, Box GM, Eccles SA. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands. Clin. Exp. Metastasis. 1999;17(7):631–639
  40. Nouri AM, Thompson C, Cannell H, Symes M, Purkiss S, Amirghofran Z. Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumor cell lines. Int. J. Mol. Med. 2000;6(4):495–500
  41. Longva KE, Blystad FD, Stang E, Larsen AM, Johannessen LE, Madshus IH. Ubiquination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 2002;156(5):843–854
  42. Guo CB, Cui NB, Yu GY, Liu DX, Meng SC, Song Q. Effects of cerulenin on the endogenous fatty acid synthetic activity in squamous cell carcinoma of the oral cavity. J. Oral Maxillofac. Surg. 2003;61(8):909–912
  43. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89(3):331–340
  44. Holbro T, Civenni G, Hynes NE. The ErB receptors and their role in cancer progression. Exp. Cell Res. 2003;284(1):99–110
  45. Gelderblom WC, Abel S, Smuts CM, Swanevelder S, Snyman SD. Regulation of fatty acid biosynthesis as a possible mechanism for the mitoinhibitory effect of fumonisin B1 in primary rat hepatocytes. Prostag. Leukotr. Essent. Fatty Acids. 1999;61(4):225–234
  46. Akimoto N, Sato T, Sakiguchi T, Kitamura K, Kohno Y, Ito A. Cell proliferation and lipid formation in hamster sebaceous gland cells. Dermatology. 2002;204(2):118–123

PII: S1368-8375(04)00027-2

doi: 10.1016/j.oraloncology.2004.01.011

Oral Oncology
Volume 40, Issue 7 , Pages 728-735 , August 2004

Article Tools

* Image Usage & Resolution